By John Vandermosten, CFA NASDAQ: CING READ THE FULL CING RESEARCH REPORT Cingulate, Inc. (NASDAQ: CING) reported 2025 results on March 18th, 2026. The company generated no revenue and recorded ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

NextNav (NASDAQ:NN) used its fourth-quarter 2025 earnings call to highlight progress in the Federal Communications Commission’s (FCC) process to advance resilient positioning, navigation and timing ...

Capital Infusion -- $15.9 million raised from Coastland Capital and Janus Henderson through a private placement, with a potential additional $15 million tranche contingent on milestone achievement.

Such forward-looking statements which may relate to NextNav forecast of future results, future prospects, developments and business strategies are subject to known and unknown risks, uncertainties and ...

There is a new, U.S.-based, environmentally friendly method for mining rare-earth elements used in consumer electronics, ...

Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of ...

Learn the essential criteria for medical device commercialization in 2026, from AI to global compliance and market trends.

As biopharma M&A activity ramps back up, strategy is shifting to no longer focus on securing the next blockbuster drug, but instead to ink deals that build out capabilities across the entire drug ...

The medical device industry faces increasing pressure to accelerate time-to-market while still maintaining quality and regulatory compliance. COVID-19 shifted expectations, forcing manufacturers to ...

South Korean Woori IO, a developer of noninvasive continuous glucose monitors, believes new FDA rules regarding wearables will accelerate the company’s commercialization process. Woori, which was ...